Published: Mar 13, 2024, 23:25 IST | Updated: Mar 13, 2024, 23:25 IST
An experimental drug designed with the help of artificial intelligence (AI) to target an aggressive and often fatal lung disease has entered phase 2 clinical trials in China and the United States. Watch in for more details!